Osteoporosis management in prostate cancer patients treated with androgen deprivation therapy
about
Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical reviewRegulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor.Cancer treatment-related bone disease.Osteoporosis Preventive Practice Between Veteran and Nonveteran Older Adults: Findings From Patient-Reported DataBone health in the prostate cancer patient receiving androgen deprivation therapy: a review of present and future management options.Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer.Roles of prohibitin in growth control and tumor suppression in human cancersDevelopment and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment.Management of complications of androgen deprivation therapy in the older man.The current practice of screening, prevention, and treatment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer.Bone densitometric assessment and management of fracture risk in Indian men of prostate cancer on androgen deprivation therapy: Does practice pattern match the guidelines?Bone density testing among prostate cancer survivors treated with androgen-deprivation therapyPatterns of bone mineral density testing in men receiving androgen deprivation for prostate cancerManagement of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer.A new era for castrate resistant prostate cancer: a treatment review and update.Bone health care for patients with prostate cancer receiving androgen deprivation therapy.Bone health management in men undergoing ADT: examining enablers and barriers to care.The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer.
P2860
Q24597422-86CE89FE-3732-438F-848E-09B448617879Q30424724-586F661B-3249-4B95-A80D-AEDC3A4F6B69Q30438185-D4739263-7114-47B7-8C84-EB1906719A73Q31142571-B994D3BA-9E1A-424A-A7E0-57BEA90704B0Q33754036-0129A0CF-2EE4-44DC-8A96-5F1FB4FB8C98Q33789201-54258DBB-96DB-4DE2-AAE1-4223F2A82D65Q34497715-AB90FB97-F335-4A39-B7F5-AE3F8D57CF74Q34615270-7B14B638-2A2C-4AA7-8A0C-8326F0946618Q34782101-22C5CDB9-5783-403B-B393-D98F69950A36Q35954808-9723CD7F-3986-41B0-B923-FC93F596FBD2Q36628819-2FF4F2D5-084E-4E54-BD7F-CA35F0B4A071Q36898869-796104C9-BF6B-4B14-9CE1-247C784631B1Q37231394-D85454BB-B1DB-4404-A1AA-E4874642C9E8Q37583687-D4AC2615-3211-4EAB-80EB-5D0BA10E13EFQ37985547-5FFD4133-4A7F-4A8F-AC03-9E2485230886Q38207463-EC6E0AC0-3173-46D4-B1EC-CF95BFF826B1Q41666599-EFB66B5B-6CB4-4CE9-A6C3-8851606C4C37Q47619304-7C07D149-2B74-4DF8-B97B-B7DFE4A3A49F
P2860
Osteoporosis management in prostate cancer patients treated with androgen deprivation therapy
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Osteoporosis management in pro ...... h androgen deprivation therapy
@ast
Osteoporosis management in pro ...... h androgen deprivation therapy
@en
type
label
Osteoporosis management in pro ...... h androgen deprivation therapy
@ast
Osteoporosis management in pro ...... h androgen deprivation therapy
@en
prefLabel
Osteoporosis management in pro ...... h androgen deprivation therapy
@ast
Osteoporosis management in pro ...... h androgen deprivation therapy
@en
P2093
P2860
P1476
Osteoporosis management in pro ...... h androgen deprivation therapy
@en
P2093
Christine Handanos
Ellen F T Yee
Glen H Murata
Robert E White
P2860
P2888
P304
P356
10.1007/S11606-007-0291-4
P577
2007-07-17T00:00:00Z